CEO SUMMARY: Some in the lab industry had high hopes that passage of the Protecting Access to Medicare Act (PAMA) last year would favorably resolve a number of important issues. However, those hopes were dashed following the September 25 release by CMS of a proposed rule setting out how it will collect market test prices […]
Labs React with Criticism to Proposed ADLT Rule
Medicare officials seem prepared to interpret and implement PAMA in an unexpected manner
- By Joseph Burns
- > From the Volume XXII No. 15 - October 26, 2015 Issue
- Tags: acla, adlts, american clinical lab, american clinical laboratory, apf, clfs, clia, clia certificate, clia certificates, clinical diagnostic laboratory, clinical lab, clinical laboratories, Clinical Laboratory, Clinical Laboratory Fee Schedule, clinical labs, dark report, diagnostic lab, diagnostic lab test, diagnostic laboratory, diagnostic laboratory tests, hie, impac, lab industry, lab test, lab test companies, lab test prices, lab tests, laboratories, laboratory association, laboratory fee schedule, laboratory test, laboratory tests, Medicare, Medicare Administrative Contractor, Medicare Part B, molecular pathology, Protecting Access to Medicare Act (PAMA), rina wolf, the dark report, xifin
